Status:
COMPLETED
Automated vs Conventional Perioperative Glycemic Control in Diabetic Patients Undergoing Cardiopulmonary Bypass Surgery
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Diabetes
Cardiopulmonary Bypass
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
The purpose of this randomized controlled trial is to evaluate a fully automated algorithm for the establishment of glycemic control in diabetic patients and to compare the results with routine manage...
Detailed Description
Upon admission of the patients to the hospital, demographic and physiological data will be collected including waist circumference and BMI. A set of baseline laboratory tests will be done for each pat...
Eligibility Criteria
Inclusion
- Type I or type II diabetic patients from both genders aged between 40 - 75 years, who are ASA III-IV undergoing Cardiopulmonary Bypass surgery under general anesthesia for more than 4 hours and requiring the insertion of an arterial line.
Exclusion
- Critically ill patients ASA V
- Pregnant patients
- Patients' refusal to consent
- Emergency or lifesaving cases
Key Trial Info
Start Date :
May 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2021
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT03314272
Start Date
May 16 2018
End Date
February 4 2021
Last Update
January 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut Medical Center
Beirut, Lebanon